Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Nafamostat | IC50 | 5.0 [1] | |
| Nafamostat | Ki | 0.53 [1] | |
| (2R)-N-(4-Carbamimidoylphenyl)-2-cyclohexyl-2-[(4-fluorophenyl)sulfonylamino]acetamide | IC50 | 90.0 [1], 190.0 [2], 1290.0 [3] | |
| (2R)-N-(4-Carbamimidoylphenyl)-2-cyclohexyl-2-[[4-(trifluoromethyl)phenyl]sulfonylamino]acetamide | IC50 | 680.0 [1], 850.0 [2], 3150.0 [3] | |
| (2R)-N-(4-Carbamimidoylphenyl)-2-cyclohexyl-2-[(4-methylphenyl)sulfonylamino]acetamide | IC50 | 33.0 [1], 38.0 [2], 990.0 [3] | |
MLA | "Quest Database™ Serine protease hepsin Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 6 Dec. 2025, https://www.aatbio.com/data-sets/serine-protease-hepsin-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 6). Quest Database™ Serine protease hepsin Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/serine-protease-hepsin-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |